Dementia, Vascular: Clinical Trials

7 trials for Dementia, Vascular, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 5, Active not recruiting 1, Enrolling by invitation 1

Follow Dementia, Vascular: new trials by email Literature Review of Dementia, Vascular trials Research Report on Dementia, Vascular

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
Atorvastatin 40 Mg Oral Tablet, Placebo - Dementia, Mixed, Dementia, Vascular
Phase 4Active not recruitingMonash University3412019-09-192025-05-22
Efficacy of Pain Treatment on Depression in Patients With Dementia
Paracetamol, Buprenorphine, Paracetamol placebo - Depression, Pain
Phase 4CompletedUniversity of Bergen1632014-08-012017-04-04
Imaging of Brain Amyloid Plaques in the Aging Population
Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies
Phase 4Enrolling by invitationMayo Clinic80002008-04-012026-06-23
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
Cilostazol, Aspirin - Vascular Dementia, Stroke
Phase 4CompletedPeking University First Hospital2002008-03-012015-05-06
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
hydrocodone/APAP w placebo PRN, hydrocodone/APAP, placebo with hydrocodone/APAP PRN - Alzheimer Disease, Dementia
Phase 4CompletedVA Office of Research and Development112007-10-012015-11-20
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Cerebrolysin, 0.9% Saline Solution - Vascular Dementia
Phase 4CompletedEver Neuro Pharma GmbH2422006-10-012024-02-21
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
donepezil hydrochloride (Aricept) - Vascular Dementia
Phase 4CompletedEisai Inc.362005-09-012012-05-04

Narrower conditions

Alzheimer Disease (3)  ·  Dementia (3)  ·  Lewy Body Disease (2)  ·  Pain (2)  ·  Agnosia (1)  ·  Cognitive Dysfunction (1)  ·  Dementia, Multi-Infarct (1)  ·  Depression (1)  ·  Frontotemporal Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Mixed Dementias (1)  ·  Psychomotor Agitation (1)  ·  Stroke (1)

Broader conditions

Arterial Occlusive Diseases (7)  ·  Arteriosclerosis (7)  ·  Brain Diseases (7)  ·  Cardiovascular Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cerebrovascular Disorders (7)  ·  Intracranial Arterial Diseases (7)  ·  Intracranial Arteriosclerosis (7)  ·  Leukoencephalopathies (7)  ·  Mental Disorders (7)  ·  Nervous System Diseases (7)  ·  Neurocognitive Disorders (7)  ·  Vascular Diseases (7)  ·  Dementia (4)  ·  Neurodegenerative Diseases (3)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)  ·  Acetaminophen (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Buprenorphine (1)  ·  Cilostazol (1)  ·  Donepezil (1)  ·  Saline Solution (1)  ·  Tablets (1)  ·  cerebrolysin (1)  ·  oxycodone-acetaminophen (1)  ·  tau Proteins (1)

Sponsors

Eisai Inc. (1)  ·  Ever Neuro Pharma GmbH (1)  ·  Mayo Clinic (1)  ·  Monash University (1)  ·  Peking University First Hospital (1)  ·  University of Bergen (1)  ·  VA Office of Research and Development (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)  ·  Norway (1)  ·  Philippines (1)  ·  Russia (1)

Top investigators

Andrea Snow, PhD MS BS (1)  ·  Ane Erdal, PhD candidate (1)  ·  Elisabeth Flo, PhD (1)  ·  Huang Yining, MD PhD (1)  ·  Jacqueline Dominguez (1)  ·  Philipp Novak, PhD (1)  ·  Sophia Zoungas, MBBS, FRACP (1)  ·  Val Lowe, M.D. (1)

Results publications

PMID 20656516, PMID 29487556, PMID 29725986, PMID 33189083, PMID 35833913, PMID 37920607

NIH funding

R01AG011378 (1), U01AG006786 (1)